Innoblative Featured in LSI’s The Lens: CEO Rick Stark on Advancing Breast-Conserving Therapy
We’re honored to share that Innoblative Designs is featured in the July 2026 issue of The Lens, LSI’s magazine for medtech
We’re honored to share that Innoblative Designs is featured in the July 2026 issue of The Lens, LSI’s magazine for medtech
The University of Texas Medical Branch (UTMB) is enrolling patients in a U.S. feasibility study evaluating the investigational SIRA radiofrequency
CHICAGO, July 16, 2024 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast
CHICAGO, July 16, 2024 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast
July 27, 2023 /Medtech Outlook/ – “Our mission is to develop and commercialize novel products to intraoperatively ablate surgical margins
July 27, 2023 /Medtech Outlook/ – “Our mission is to develop and commercialize novel products to intraoperatively ablate surgical margins
Novel device is designed specifically for patients undergoing breast-conserving surgery (BCS) for breast cancer CHICAGO, April 27, 2023 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative),
CHICAGO, Sept. 4, 2019 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company committed to developing next generation, advanced-energy surgical solutions, including